Skip to content
Learn Motion
ExploreHow it worksMembership
Log in
Learn Motion

Why AI-Designed Drugs Haven't Changed Medicine Yet

1The Promise and the Puzzle2From Molecule to Medicine: The Journey a Drug Must Survive3Where AI Actually Helps in the Pipeline4The Prediction Gap: When a Good Molecule Meets a Real Body5The Long, Expensive Road of Clinical Trials6Money, Incentives, and the Business of Drug Development7Regulation, Evidence, and Trust8What Would Have to Change
The Prediction Gap: When a Good Molecule Meets a Real Body

When the model meets a case it has never seen

4 / 4
Watch what happens as the animation moves. The model is trained on a set of examples — molecules and targets that have already been studied. That set is not a fair sample of all chemistry or all biology; it is concentrated where research has already happened. Now the model meets a case outside that set. It still produces a prediction, and it still sounds confident, but nothing in its training tells it how to handle this situation. That is the mismatch you are seeing. Notice that the problem has two shapes. Sometimes there is simply no relevant data — a gap. Sometimes the data exists but over-represents certain molecules, targets, or patient groups — a bias. In both cases, the model's confidence is not the same as its accuracy on new biology.
0:00 / 0:00

A model learns from data that already exists — molecules that have been made and measured, targets that have been studied. That data is not a random sample of chemistry or biology. It is concentrated where research has already happened, which means the model is strongest on molecules and targets that resemble what it was trained on, and weakest on genuinely new ones.

The animation shows this directly. The model is trained on a limited set of examples, then meets a biological case outside that set. Its prediction is confident but unreliable, because nothing in its training tells it how to handle the new situation. The same problem appears in two forms: gaps, where no relevant data exists at all, and bias, where the data exists but over-represents certain kinds of molecules, targets, or patient populations. Both mean the model's confidence is not the same as its accuracy on new biology.

Previous4 / 4Next

Learn Motion

Generate a course. Learn it properly.

Operated by Wuhan Daoyin Technology Co., Ltd.

Contact: [email protected]
Privacy PolicyTerms of Service

© 2026 Learn Motion